Doctor profile · Federal record
Dr. Arthur Mandelin, MD/PHD
Rheumatology Physician (CMS: Rheumatology) · Internal Medicine Physician · Chicago, IL
- NPI 1669655569
- Accepts Medicare
- MIPS 91.3 / 100 · 2023
- 24 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
675 N Saint Clair St, Suite 14-100
Chicago, IL 606115975
(312) 695-8628
fax (312) 695-0114
Credentials & registration
- NPI registered
- December 2007 — 19 yrs on file
- Profile last updated
- July 9, 2008
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Illinois #036-118442
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1669655569. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
90,011
Distinct HCPCS
10
Medicare allowed
$1,496,281
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 29,671 | 20 | $6 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 14,790 | 20 | $0 | |
J3380 |
Injection, vedolizumab, 1 mg | 11,700 | 11 | $22 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 11,150 | 27 | $13 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 9,200 | 32 | $42 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 7,065 | 38 | $33 | |
J9312 |
Injection, rituximab, 10 mg | 2,000 | 14 | $72 | |
J7325 |
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 1,920 | 20 | $9 | |
J3489 |
Injection, zoledronic acid, 1 mg | 531 | 108 | $8 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 432 | 209 | $68 |
In context: peer comparison
Among 36 peers in Chicago Rheumatology Physician, average services per provider: 1,230. This provider delivers 73× the peer median.Open Payments
Industry payments received
All-time total
$12,824
Transactions
29
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Pfizer INC. | 15 | $6,447.21 | |
| Abbvie INC. | 5 | $3,845.70 | |
| Janssen Biotech, INC. | 3 | $2,306.25 | |
| Novartis Pharmaceuticals Corporation | 2 | $83.25 | |
| Ge Healthcare | 1 | $62.00 | |
| Ani Pharmaceuticals, INC. | 1 | $46.27 | |
| Amgen INC. | 1 | $17.81 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $15.47 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,407
Patients
309
Total drug cost
$1,823,759
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 200 | 53 | $9,734 |
| Prednisone | Generic | 195 | 57 | $2,120 |
| Hydroxychloroquine Sulfate | Generic | 129 | 40 | $9,270 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 123 | 23 | $4,364 |
| Allopurinol | Generic | 122 | 33 | $2,256 |
| Leflunomide | Generic | 101 | 24 | $11,527 |
| Tramadol Hcl | Generic | 100 | 20 | $921 |
| Xeljanz Xr (Tofacitinib Citrate) | Brand | 73 | 11 | $457,156 |
| Colchicine | Generic | 65 | 17 | $4,351 |
| Rinvoq (Upadacitinib) | Brand | 63 | 0 | $421,024 |
Hospital affiliations
Frequently asked questions
What is Dr. Arthur Mandelin's medical specialty?
Dr. Arthur Mandelin practices Rheumatology Physician in Chicago, IL.
Where does Dr. Arthur Mandelin practice?
Dr. Arthur Mandelin practices at 675 N Saint Clair St, Chicago, IL 606115975. Office phone: 3126958628.
What is Dr. Arthur Mandelin's NPI?
Dr. Arthur Mandelin's National Provider Identifier (NPI) is 1669655569, issued by NPPES.
Does Dr. Arthur Mandelin accept Medicare assignment?
Yes. Dr. Arthur Mandelin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Arthur Mandelin commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, vedolizumab, 1 mg (HCPCS J3380). Source: CMS Medicare Physician & Other Practitioners file.